PHENYLARTHRITE ANTI-INFLAMMATORY INJECTABLE SOLUTION FOR HORSES AND DOGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

PHENYLBUTAZONE

Available from:

VETOQUINOL S.A.

Class:

Veterinary Medicine

Therapeutic group:

DOG | HORSE | BITCH | CASTRATE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT

Therapeutic area:

MUSCULOSKELETAL SYSTEM

Therapeutic indications:

MUSCULOSKELETAL CONDITIONS | ARTHRITIS | ARTHROSIS | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | OSTEITIS | OSTEOARTHRITIS | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE

Authorization status:

Registered

Authorization date:

0000-00-00

Patient Information leaflet

Phenylarthrite anti-inflammatory injectable solution for horses
and dogs draft label
40447/0701 100mL vial and box
Version 1 11/10/01
page 1 of 4
_Vial main panel_
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
PHENYLARTHRITE
ANTI-INFLAMMATORY INJECTABLE SOLUTION
FOR HORSES AND DOGS
ACTIVE CONSTITUENT:
PHENYLBUTAZONE 0.2G/ML
An aid in the treatment of painful musculoskeletal
conditions such as arthritis,
bursitis, certain causes of lameness,
soft tissue inflammation and osteoarthritis
100ML
_(logo)_
Vétoquinol
InfoPEST
✔
Verified
Phenylarthrite anti-inflammatory injectable solution for horses
and dogs draft label
40447/0701 100mL vial and box
Version 1 11/10/01
page 2 of 4
_Vial ancillary panel 1_
DIRECTIONS FOR USE
NOT TO BE USED IN FOOD PRODUCING ANIMALS
CONTRAINDICATIONS: THIS PRODUCT IS CONTRAINDICATED FOR USE IN
HORSES AND DOGS
WITH CARDIAC, HEPATIC AND RENAL INSUFFICIENCIES.
PRECAUTIONS:
Deep intramuscular injections should
be used only exceptionally on horses since
undesirable local reactions may occur.
Animals
suffering from vascular fragility or coagulation defects should
receive a lower
dose rate and injections should not be repeated.
DOSAGE & ADMINISTRATION
INTRAVENOUS ROUTE
HORSES: 4mL/100kg of body weight every day or every 2 days
according to the
severity of the case.
FOALS: 1.2-2mL/100kg of body weight every day or every 2 days
according to the
severity of the case.
DOGS: 1mL/15kg of body weight daily.
DEEP INTRAMUSCULAR ROUTE
HORSES: 4-6mL/100kg of body weight the first day, 4mL/100kg
of body weight the
second day then 2 mL the following days for 1-4 days.
FOALS: 1.2-2mL/100kg of body weight to be repeated24 to
48 hours later according
to the severity of the condition.
DOGS: 1mL/15kg of body weight daily.
MEAT WITHHOLDING PERIOD (HORSES): NOT TO BE USED IN HORSES
INTENDED FOR HUMAN CONSUMPTION.
Dispose of empty cont

Summary of Product characteristics

PRODUCT NAME: PHENYLARTHRITE 
PAGE: 1 OF 4 
THIS REVISION ISSUED: OCTOBER, 2008 
MATERIAL SAFETY DATA SHEET 
ISSUED BY: AUSRICHTER PTY LTD 
PHONE: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND) 
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY 
AUSRICHTER PTY LTD 
PHONE: [phone]
2/21 CHESTER ST 
FAX: [phone]
CAMPERDOWN NSW 2050 
[e-mail]
SUBSTANCE:  
Solution of phenylbutazone.

TRADE NAME:  
PHENYLARTHRITE 
PRODUCT CODE:  40447 
PRODUCT USE:  
Anti-inflammatory injectable solution for horses and dogs.

CREATION DATE: 
OCTOBER, 2008 
REVISION DATE: 
OCTOBER, 2008 
SECTION 2 - HAZARDS IDENTIFICATION 
STATEMENT OF HAZARDOUS NATURE  
This product is classified as: Xn, Harmful. Hazardous according to
the criteria of ASCC.  
Not a Dangerous Good according to the Australian Dangerous Goods
(ADG) Code.

RISK PHRASES: R22. Harmful if swallowed.  
SAFETY PHRASES: S20, S25, S45. When using, do not eat or drink.
Avoid contact with eyes. In case of accident or if 
you feel unwell, contact a doctor or Poisons Information Centre
immediately (show this MSDS where possible).  
SUSDP CLASSIFICATION: S4 
ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the
ADG Code. 
UN NUMBER: None allocated 
EMERGENCY OVERVIEW 
PHYSICAL DESCRIPTION & COLOUR: Pale yellow liquid. 
ODOUR: No odour. 
MAJOR HEALTH HAZARDS: harmful if swallowed. This is a
physiologically active product and so contact should be 
minimised, especially if the user is taking a form of medication,
as interactions can sometimes give unexpected and 
undesired results.  
POTENTIAL HEALTH EFFECTS 
INHALATION: 
SHORT TERM EXPOSURE: Available data indicates that this product
is not harmful. In addition product is unlikely to 
cause any discomfort or irritation. 

LONG TERM EXPOSURE: No data for health effects associated with long
term inhalation. 

SKIN CONTACT: 
SHORT TERM�